ReviewCurrent treatment options in oncology2017
Dermatofibrosarcoma Protuberans.
Review in Current treatment options in oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.JAMA dermatology · 2019Pooled it
- The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans.The Pan African medical journal · 2019Pooled it
- Article
- Article
- Anesthetic and Analgesic Management of Pediatric Patients for Staged Repeat Same-Day Surgery.Case reports in anesthesiology · 2026Article
- Fifth-Time Recurrence of Dermatofibrosarcoma Protuberans at Distinct Sites: A Rare Case Report.Clinical case reports · 2025Article
- Overcoming Mohs Limitations in Treating DFSP: Retrospective Analysis of a Novel Excision Technique.Life (Basel, Switzerland) · 2025Article
- LMNA-NTRK1-rearranged spindle cell neoplasm with multiple relapses: a case report and literature review.Frontiers in medicine · 2025Article
- Racial and Ethnic Differences in Patient Presentation and Treatments in Head and Neck Dermatofibrosarcoma Protuberans.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024Article
- A Depressed Bluish-black Plaque on the Shoulder: A Quiz.Acta dermato-venereologica · 2024Article
- Article
- Article
- Bednar's tumor at right shoulder in an adult male: a case report of a rare entity.Annals of medicine and surgery (2012) · 2024Article
- Article
- Fibrosarcomatous dermatofibrosarcoma protuberans: a rapidly growing 30 cm mass on the posterior scalp.Asian biomedicine : research, reviews and news · 2023Article
- Article
- Atrophic dermatofibrosarcoma protuberans: Two case reports and literature review.Frontiers in oncology · 2023Article
- First Case of Allochronic Onset of Two Primary Dermatofibrosarcoma Protuberans Lesions Proved by COL1A1-PDGFB Fusion Gene Analysis.Acta dermato-venereologica · 2022Article
- Diagnosis and differential diagnosis of dermatofibrosarcoma protuberans: Utility of high-resolution dynamic contrast-enhanced (DCE) MRI.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2022Article
- Low-Grade Fibromyxoid Sarcoma of the Back.Cureus · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
opinion statementDermatofibrosarcoma protuberans (DFSP) is a slow growing tumor with a very low metastatic potential but with significant subclinical extension and great capacity for local destruction. Thus, the first surgeon approached with such challenging tumor must attempt to cure the patient with a method that spares healthy tissue and ensures an optimal oncological, functional, and esthetic result. The treatment of DFSP often requires a multidisciplinary approach. Depending on location, dermatologic surgeons, surgical oncologists, head and neck surgeons, neurosurgeons, plastic surgeons, and occasionally medical oncologists may be involved with the management. Mohs micrographic surgery (MMS) is the preferred method when available. In our institution, most of the DFSP cases are often advanced cases; thus, dermatologic surgeons obtain clear margins peripherally and other surgical specialties assist with resection of the fascia and any critical deeper structures. When MMS is not available, wide local excision (at least 2- to 3-cm margins of resection) with exhaustive pathologic assessment of margin status is recommended, and it is best to confirm tumor extirpation prior to any reconstruction. Subclinical extension of the tumor could be related to the size; how long it has been growing or histological markers that are unknown right now. No clinical trials comparing MMS vs WLE are available, and further research should be focused on these subjects as well as the use of imatinib and other targeted therapies for recurrent and metastatic tumors and for neoadjuvant treatment.
Indexed as
Identifiers
28795284What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.